Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.

Emily Banerjee,Bridget Brassil,Anna Stadelman ,Nathaniel M. Lewis,Jennifer L. Farrar,Kennedy Houck,Meaghan Abrego,Tiffany Henderson,Michelle Canning,Anna Kocharian,Bailey Glenn,Caleb Wiedeman,Elizabeth McCarty,Katharine Saunders,Michael Eberhart ,Daniel C. Payne,Brooklyn White,Michael Pietrowski,Cristina Meza,Adam L. Cohen,Jade Murray-Thompson,Amanda B. Payne,Anil Mangla ,Elizabeth Torrone ,Nikki Kupferman,Sandra Miranda De León,Meagan McLafferty,Brandon Blouse,Emma Creegan,Erin Youngkin,Rachael Birn,Amy Fothergill,Logan C. Ray,Abdoulaye Diedhiou,Joshua Vance,Susan Soliva,Jessica Marcinkevage,Dawn Nims

doi:10.1016/j.ajt.2023.01.003

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.

Emily Banerjee, Bridget Brassil

Open Access

https://doi.org/10.1016/j.ajt.2023.01.003

Copy DOI

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons	Publication Date: Feb 1, 2023
Citations: 4

Affiliation: Computer Emergency Response Team

#Persons Who #Demographic Characteristics + Show 1 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.

Full Text